Impact of Curcumin-Induced Changes in P-Glycoprotein and CYP3A Expression on the Pharmacokinetics of Peroral Celiprolol and Midazolam in Rats

Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

Ann‐Lii Cheng, Chih‐Hung Hsu, Jen‐Kou Lin et al. · PubMed · 2001 · 2.1K citations

Urinary Bladder Cancer, Chemopreventive Agent, Oncology +15

Phase I Clinical Trial of Oral Curcumin

Ricky A. Sharma, Stephanie A. Euden, Sharon L. Platton et al. · Clinical Cancer Research · 2004 · 1.2K citations · Full text

Trends in use of complementary and alternative medicine by US adults: 1997-2002.

Hilary A. Tindle, Roger B. Davis, Russell S. Phillips et al. · PubMed · 2005 · 1.1K citations

The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin

Bernd Greiner, Michel Eichelbaum, Péter Fritz et al. · Journal of Clinical Investigation · 1999 · 916 citations · Full text

Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer.

Ricky A. Sharma, Heather R. McLelland, K A Hill et al. · PubMed · 2001 · 829 citations

Oncology, Chemoprevention Strategy, Gastrointestinal Oncology +14